Abstract

In Caenorhabditis elegans, the dosage compensation complex (DCC) specifically binds to and represses transcription from both X chromosomes in hermaphrodites. The DCC is composed of an X-specific condensin complex that interacts with several proteins. During embryogenesis, DCC starts localizing to the X chromosomes around the 40-cell stage, and is followed by X-enrichment of H4K20me1 between 100-cell to comma stage. Here, we analyzed dosage compensation of the X chromosome between sexes, and the roles of dpy-27 (condensin subunit), dpy-21 (non-condensin DCC member), set-1 (H4K20 monomethylase) and set-4 (H4K20 di-/tri-methylase) in X chromosome repression using mRNA-seq and ChIP-seq analyses across several developmental time points. We found that the DCC starts repressing the X chromosomes by the 40-cell stage, but X-linked transcript levels remain significantly higher in hermaphrodites compared to males through the comma stage of embryogenesis. Dpy-27 and dpy-21 are required for X chromosome repression throughout development, but particularly in early embryos dpy-27 and dpy-21 mutations produced distinct expression changes, suggesting a DCC independent role for dpy-21. We previously hypothesized that the DCC increases H4K20me1 by reducing set-4 activity on the X chromosomes. Accordingly, in the set-4 mutant, H4K20me1 increased more from the autosomes compared to the X, equalizing H4K20me1 level between X and autosomes. H4K20me1 increase on the autosomes led to a slight repression, resulting in a relative effect of X derepression. H4K20me1 depletion in the set-1 mutant showed greater X derepression compared to equalization of H4K20me1 levels between X and autosomes in the set-4 mutant, indicating that H4K20me1 level is important, but X to autosomal balance of H4K20me1 contributes only slightly to X-repression. Thus H4K20me1 by itself is not a downstream effector of the DCC. In summary, X chromosome dosage compensation starts in early embryos as the DCC localizes to the X, and is strengthened in later embryogenesis by H4K20me1.

Highlights

  • Dosage compensation equalizes X chromosome gene expression between sexes

  • We found that the dosage compensation complex (DCC) starts repressing X chromosomes in early embryogenesis, but average X-linked transcript levels remain higher in hermaphrodite embryos compared to males until the larval stage

  • The DCC increases H4K20 monomethylation on the X chromosomes, which is important for dosage compensation

Read more

Summary

Introduction

Dosage compensation equalizes X chromosome gene expression between sexes. Different animals use different strategies of dosage compensation by co-opting diverse mechanisms of gene regulation to the X chromosome [1]. Dosage compensation transcriptionally inactivates one of the two X chromosomes in XX females to equalize overall X expression to that of XY males. Xchromosome dosage compensation is established during, and is essential for development in mammals, D. melanogaster and C. elegans. In D. melanogaster, the dosage compensation complex (male specific lethal (MSL) complex) localizes to the X chromosome at the late blastoderm/early gastrula stage [5,6]. Mutations in any of the four MSL complex members slow development and lead to lethality at the late larval and early pupal stages [7,8,9]. In C. elegans, mutations in several dosage compensation complex (DCC) subunits are maternal effect lethal, where the progeny of homozygous null mutant worms die at early larval stages [10,11,12]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call